Several case reports and retrospective cohort studies have described a marginal benefit with the use of internal cardioverter defibrillators in patients with cardiac amyloidosis. Detection of ...

Expert Rev Cardiovasc Ther. 2010;8(7):1007-1113. Recurrence of amyloidosis in the cardiac allograft is a consideration in cardiac transplant. Amyloid deposit in the cardiac allograft was reported ...

Hereditary transthyretin (hATTR) amyloidosis is a rare disease that runs in families. It is caused by the buildup of toxic ...

chair of the writing group for the 2020 American Heart Association Scientific Statement on Cardiac Amyloidosis and a professor of medicine at the Smidt Heart Institute at Cedars-Sinai in Los Angeles.